Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,406 JPY | +0.93% | -2.29% | -0.99% |
04-18 | Nxera Pharma Initiates Restricted Stock Unit Plans, Starting with Shares Worth 164 Million Yen in Total in May | MT |
04-17 | Nxera Pharma's Neuro Drug NBI-1117568 Passed Preclinical Toxicity Test | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.99% | 821M | |
-3.30% | 90.75B | |
-4.34% | 39.03B | |
-17.08% | 31.85B | |
+61.22% | 26.26B | |
-22.15% | 14.13B | |
-9.36% | 12.87B | |
-11.39% | 11.6B | |
-46.06% | 10.91B | |
+2.17% | 8.89B |
- Stock Market
- Equities
- 4565 Stock
- News Nxera Pharma Co., Ltd.
- Transcript : Sosei Group Corporation Presents at JPMorgan 40th Annual Healthcare Conference, Jan-10-2022 09